Thus, in the present study we tested the hypothesis that diabetic subjects heterozygous for the SOD3 R213G genetic variation, which entails lower antioxidant capacity in tissues, have increased risk of cardiovascular disease and heart failure. This evidence concerns the gene SOD3 and heart failure.